Related Experiment Videos
WHO 2019 guidelines on drug-resistant tuberculosis treatment: based on evidence or expert opinion?
Lorenzo Guglielmetti1,2, Helena Huerga3, Uzma Khan4
1Médecins Sans Frontières, Paris, France lorenzo.guglielmetti@paris.msf.org.
The European Respiratory Journal
|March 7, 2020
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Tuberculosis prevalence among children with severe acute malnutrition: a systematic review and meta-analysis.
medRxiv : the preprint server for health sciences·2026
Comparison of three linezolid management strategies for peripheral neuropathy in multidrug- or rifampicin-resistant tuberculosis treatment: a target trial emulation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Beyond Heritable PAH: Pulmonary Hypertension in Genetic Syndromes.
The European respiratory journal·2026
Solving an enigma: the BMP-9/10 axis as a key regulator of pulmonary vascular resilience.
The European respiratory journal·2026
European Respiratory Society clinical practice guidelines update for the treatment of pulmonary arterial hypertension.
The European respiratory journal·2026
From donor to durable graft: modern paradigms in lung transplantation.
The European respiratory journal·2026
The Role of Inflammation in the Pathogenesis of Pulmonary Fibrosis: Mechanisms and Treatment Implications.
The European respiratory journal·2026
ANAPC7 promotes triple-negative breast cancer progression through ANAPC2-dependent degradation of PCGF2 and activation of STAT3.
Molecular cancer research : MCR·2026
pH-Responsive drug delivery system for tumor therapy.
Nanoscale·2026
Spatiotemporally controlled degradation of CDK6 via light-triggered ROS generation: uncovering the proximity effect-mediated dual target depletion.
Organic & biomolecular chemistry·2026
Targeting RAS for Pancreatic Cancer Interception.
Cancer discovery·2026